Get the Stockscreener App
1.04
9.57%
-0.11
After Hours:
1.03
-0.01
-0.96%
Park Ha Biological Technology Co Ltd stock is traded at $1.04, with a volume of 4.27M.
It is down -9.57% in the last 24 hours and down -94.92% over the past month.
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complimentary after-sales beauty services in its physical stores.
See More
Previous Close:
$1.15
Open:
$1.15
24h Volume:
4.27M
Relative Volume:
10.85
Market Cap:
$493.20M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-97.44%
1M Performance:
-94.92%
6M Performance:
-78.47%
1Y Performance:
+0.00%
1-Day Range:
$1.03
$1.16
1-Week Range:
$1.03
$41.49
52-Week Range:
$1.03
$41.49
Park Ha Biological Technology Co Ltd Stock (PHH) Company Profile
Name
Park Ha Biological Technology Co Ltd
Sector
Industry
Phone
-
Address
-
Compare PHH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PHH
Park Ha Biological Technology Co Ltd
|
1.04 | 493.20M | 0 | 0 | 0 | 0.00 |
|
PG
Procter Gamble Co
|
157.05 | 381.79B | 83.93B | 15.50B | 15.03B | 6.30 |
|
UL
Unilever Plc Adr
|
60.79 | 154.84B | 65.10B | 6.16B | 0 | 2.4569 |
|
CL
Colgate Palmolive Co
|
89.58 | 74.51B | 19.95B | 2.90B | 3.47B | 3.54 |
|
KMB
Kimberly Clark Corp
|
129.38 | 44.14B | 19.75B | 2.47B | 2.39B | 7.34 |
|
KVUE
Kenvue Inc
|
21.34 | 41.32B | 15.30B | 1.06B | 1.45B | 0.55 |
Park Ha Biological Technology Co Ltd Stock (PHH) Latest News
With Beauty Farm Medical and Health Industry Inc. (HKG:2373) It Looks Like You'll Get What You Pay For - simplywall.st
Best Stocks Under $20 Right Now - Benzinga
Why Park Ha Biological Technology Co., Ltd. (PHH) is Surging in 2025 - Insider Monkey
Why These 15 Consumer Defensive Stocks Are Surging in 2025 - Insider Monkey
Park Ha Biological Technology Co Ltd (PHH) is a good investment, but the stock may be overvalued - uspostnews.com
Company’s Banking Stock: Dissecting a 131.28% Quarterly Revenue Decline Amid Growth - investchronicle.com
Park Ha Biological Technology: Growth Potential And Profitability Concerns (NASDAQ:PHH) - Seeking Alpha
12 Consumer Discretionary Stocks Moving In Friday's Intraday Session - Benzinga
Why Park Ha Biological Technology Co Ltd (PHH) Is Surging In 2025? - Insider Monkey
Why These 15 Defensive Stocks Are Surging In 2025 - Insider Monkey
12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session - Benzinga
Why Park Ha Biological Technology Co., Ltd. (PHH) Soared Last Week - MSN
10 Micro-, Small-Cap Firms Were Last Week’s Top Performers - Insider Monkey
Acid-Responsive Biocompatible Hydrogel Modulating Tumor DNA Self-Repair Collaborated with Chemotherapy for Boosting STING Pathway-Associated Immunotherapy - ACS Publications
Best Growth Stocks to Watch in April 2025 - Investopedia
Neumora Therapeutics and Other Stocks Suffer Major Losses as Market Faces Declines - HPBL
3 Growth Stocks With High Insider Ownership And 25% Earnings Growth - Simply Wall St
Northern Vietnam province urges VSIP to build high-tech park - Theinvestor.vn
Microbot Medical Announces $7 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules - The Manila Times
The Business of Beauty Haul of Fame: Revenge of the Cheap Shampoo - The Business of Fashion
Why MicroStrategy Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket - Benzinga
Adlai Nortye Sees Significant Growth in Short Interest Amid Stock Performance Fluctuations - HPBL
Park Ha Biological Technology Shares Gain After IPO - MarketWatch
Park Ha Biological Technology Co., Ltd. Announces Closing of $4.8 Million Initial Public Offering - GlobeNewswire
NIA Selects Eight Thai Medical and Health Innovators to Break into the German and European Markets, Showcasing Strengths at Medica 2024 and Cementing Thailand's Role as a 'Medical Innovation Hub' - The Manila Times
Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering - GlobeNewswire
Decent Holding Inc. Plans $6 Million IPO for Week of January 6th (DXST) - Defense World
Applied Optoelectronics, Inc. (NASDAQ:AAOI) Short Interest Down 5.7% in November - Defense World
IPO Roundup: ServiceTitan, Jackson Acquisition II and more - MSN
Capstone Companies (OTCMKTS:CAPC) Appoints Alexander Jacobs as Chief Executive Officer and Director - Denison University
Form FWP Park Ha Biological Techn Filed by: Park Ha Biological Technology Co., Ltd. - StreetInsider
IPO Roundup: Pony AI, ServiceTitan and more (NYSEARCA:IPO) - Seeking Alpha
Park Ha Biological Aims For U.S. IPO At Sky-High Valuation (PHH) - Seeking Alpha
Hanoi establishes high-tech biological park - http://en.vietnamplus.vn/
International consortium to promote hi-tech investments in southern Vietnam IP - Theinvestor.vn
Chia Chang Vietnam Technology factory construction starts in Ha Nam - Vietnam Investment Review
In-vitro and In-Vivo Assessment of 4D Flow MRI Reynolds Stress Mapping for Pulsatile Blood Flow - Frontiers
US-China Legal Experts Jiangsu Junjin Law Firm Celebrates Their Tenth Chinese Client Successfully Listing On The US Stock Market - Nasdaq
Preparation of Antimicrobial Hyaluronic Acid/Quaternized Chitosan Hydrogels for the Promotion of Seawater-Immersion Wound Healing - Frontiers
Mussel-inspired HA@TA-CS/SA biomimetic 3D printed scaffolds with antibacterial activity for bone repair - Frontiers
Therapeutic Effects of Zoledronic Acid-Loaded Hyaluronic Acid/Polyethylene Glycol/Nano-Hydroxyapatite Nanoparticles on Osteosarcoma - Frontiers
Injectable antibacterial Ag-HA/ GelMA hydrogel for bone tissue engineering - Frontiers
Physicochemical properties and cell proliferation and adhesive bioactivity of collagen-hyaluronate composite gradient membrane - Frontiers
Initial Public Offering (IPO) News Live Feed - StockTitan
Hong Kong health authorities, Science Park offer patient data to biotech firms - South China Morning Post
MARKET DATA - The Wall Street Journal
Chemosensitization of Fusarium graminearum to Chemical Fungicides Using Cyclic Lipopeptides Produced by Bacillus amyloliquefaciens Strain JCK-12 - Frontiers
Park Ha Biological Technology Co Ltd Stock (PHH) Financials Data
There is no financial data for Park Ha Biological Technology Co Ltd (PHH). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
4.67%
2.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):